Martin Kavaliers Selected Research

propionic acid (potassium propionate)

1/2020	Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats.
1/2019	Systemic treatment with the enteric bacterial metabolic product propionic acid results in reduction of social behavior in juvenile rats: Contribution to a rodent model of autism spectrum disorder.
2/2015	Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders.
12/2014	Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders.
2/2012	Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats.
1/2007	Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Kavaliers Research Topics

Disease

10	Nausea 10/2021 - 02/2009
5	Autism Spectrum Disorder 01/2020 - 01/2007
5	Body Weight (Weight, Body) 01/2017 - 02/2009
3	Infections 01/2019 - 11/2003
3	Acute-Phase Reaction 10/2018 - 05/2012
2	Weight Loss (Weight Reduction) 05/2012 - 01/2003
2	Breast Neoplasms (Breast Cancer) 09/2009 - 02/2009
1	Neurodevelopmental Disorders 12/2014
1	Obesity 02/2012
1	Neoplasms (Cancer) 09/2009
1	Substance-Related Disorders (Drug Abuse) 07/2008
1	Bacterial Infections (Bacterial Infection) 10/2007
1	Seizures (Absence Seizure) 01/2007
1	Pain (Aches) 01/2007
1	Lordosis 12/2006
1	Hyperphagia (Overeating) 05/2006

Drug/Important Bio-Agent (IBA)

10	LipopolysaccharidesIBA 10/2018 - 01/2003
6	propionic acid (potassium propionate)IBA 01/2020 - 01/2007
5	Lithium ChlorideIBA 10/2021 - 09/2011
3	Volatile Fatty AcidsIBA 01/2019 - 01/2007
3	Oxytocin (Pitocin)FDA LinkGeneric 01/2019 - 12/2016
3	Estradiol (Delestrogen)FDA LinkGeneric 10/2018 - 02/2009
3	EndotoxinsIBA 01/2017 - 05/2012
2	Pharmaceutical PreparationsIBA 01/2013 - 02/2009
2	SaccharinIBA 06/2012 - 09/2011
2	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2012 - 01/2003
2	SolutionsIBA 09/2011 - 05/2006
2	Selective Estrogen Receptor Modulators (SERM)IBA 09/2009 - 02/2009
2	Tamoxifen FDA LinkGeneric 09/2009 - 02/2009
2	Estrogen ReceptorsIBA 09/2009 - 02/2009
1	EmeticsIBA 10/2021
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2019
1	Hormones (Hormone)IBA 10/2017
1	SteroidsIBA 10/2017
1	Estrogens (Estrogen)FDA Link 10/2017
1	Poly I-CIBA 05/2012
1	CorticosteroneIBA 06/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 02/2009
1	Estrogen Receptor betaIBA 07/2008
1	Estrogen Receptor alphaIBA 07/2008
1	Dopamine (Intropin)FDA LinkGeneric 10/2007
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2006
1	Sucrose (Saccharose)IBA 05/2006
1	Pregnanolone (Allopregnanolone)IBA 05/2006

Therapy/Procedure

2	Injections 01/2017 - 01/2013
1	Drug Therapy (Chemotherapy) 12/2016
1	Chemoprevention 02/2009
1	Intraventricular Infusions 01/2007
1	Analgesia 01/2007